These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7278432)

  • 41. [Dissolving biliary calculi: reality or myth?].
    Tor J
    Med Clin (Barc); 1983 Apr; 80(11):496-8. PubMed ID: 6865526
    [No Abstract]   [Full Text] [Related]  

  • 42. Ursodeoxycholic acid and gallstone calcification.
    Raedsch R; Stiehl A; Czygan P
    Lancet; 1981 Dec; 2(8258):1296. PubMed ID: 6118713
    [No Abstract]   [Full Text] [Related]  

  • 43. [Biliary periodicity. The value of ursolvan 200 mg].
    Med Chir Dig; 1981; 10(3):285-6. PubMed ID: 7266139
    [No Abstract]   [Full Text] [Related]  

  • 44. Lipoprotein (a) serum levels in chronic cholestatic liver disease during treatment with ursodeoxycholic acid.
    Beuers U; Ritter MM; Richter WO; Paumgartner G
    Arch Intern Med; 1990 Jul; 150(7):1542. PubMed ID: 2142412
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacological aspects and therapeutic effects of ursodeoxycholic acid.
    Leuschner U; Kurtz W
    Dig Dis; 1990; 8(1):12-22. PubMed ID: 2406049
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative studies on the effect of cadmium, cobalt, lead, and selenium on hepatic microsomal monooxygenase enzymes and glutathione levels in mice.
    Dalvi RR; Robbins TJ
    J Environ Pathol Toxicol; 1978; 1(5):601-7. PubMed ID: 102717
    [No Abstract]   [Full Text] [Related]  

  • 47. [Ursodeoxycholic acid in the treatment of dyspeptic-painful disorders of biliary origin: report of a controlled multicenter study].
    Alvisi V; Tralli M; Loponte A; D'Ambrosi A; Pavani F; Ruina M
    Clin Ter; 1982 Jan; 100(1):21-33. PubMed ID: 6759007
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of ursodeoxycholic acid (UDCA) treatment on nucleation time (NT)].
    Tazuma S; Sasaki H; Mizuno S; Nomura Y; Horiuchi I; Kajiyama G; Nakai S; Kado S; Masuda T
    Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1530-5. PubMed ID: 3184522
    [No Abstract]   [Full Text] [Related]  

  • 49. [Inhibition of the antioxidant protection, microsomal oxidation, and xenobiotic glucuroconjugation in rats with cholestasis and their regulation].
    Bushma MI; Legon'kova LF; Zverinskiĭ IV; Khomich TI; Karpovich VE; Konovalenko OV; Karaedova LM; Lashak LK
    Biull Eksp Biol Med; 1999 Feb; 127(2):194-7. PubMed ID: 10095954
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of estrogens on mixed function oxidase activity in healthy and injured liver.
    Kulcsár-Gergely J; Kulcsár A; Weisz G
    Acta Pharm Hung; 1982 Jan; 52(1):2-9. PubMed ID: 7058689
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical experiences concerning gallstones dissolution with ursodeoxycholic acid.
    Canepa A; Volpi C; Ciravegna G; Dodero M; Celle G
    Acta Gastroenterol Belg; 1980; 43(11-12):502-7. PubMed ID: 7211116
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of cholesterol gallstones with ursodesoxycholic acid (author's transl)].
    Bernades P; Bertrand L; Bouvry M; Colin R; Geffroy Y; Hecht Y; Klepping C; Lambert R; Levy VG; Michel H; Paliard P; Paris J; Quinton A
    Nouv Presse Med; 1982 Feb; 11(8):587-9. PubMed ID: 7041086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nitrite on rabbit liver mixed-function oxidase activity.
    Duthu GS; Shertzer HG
    Drug Metab Dispos; 1979; 7(5):263-9. PubMed ID: 40763
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
    Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of phenobarbital pretreatment on mixed function oxidases & lipid peroxidation during thiodemeton toxicity.
    Fawade MM; Pawar SS
    Indian J Exp Biol; 1980 Jun; 18(6):645-7. PubMed ID: 7439951
    [No Abstract]   [Full Text] [Related]  

  • 56. Combination therapy of trypsin inhibitor with ursodeoxycholic acid on cholesterol gallbladder stone.
    Tanno N; Ishizuka J; Shimoda I; Sato K; Hirano H; Koizumi M; Toyota T
    Gastroenterol Jpn; 1989 Jun; 24(3):339. PubMed ID: 2744348
    [No Abstract]   [Full Text] [Related]  

  • 57. [Preliminary experience with the use of ursodeoxycholic acid in the treatment of biliary calculosis].
    Bonfiglio M; Casamichiela M; Garagnani A
    Clin Ter; 1979 Mar; 88(5):491-7. PubMed ID: 466971
    [No Abstract]   [Full Text] [Related]  

  • 58. [A new experimental trial for dissolution of gallbladder stones].
    Shimoda I; Ishizuka H; Murakami M; Sato K; Hirano H; Tanno N; Ohira C; Koizumi M; Toyota T
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2481. PubMed ID: 2593314
    [No Abstract]   [Full Text] [Related]  

  • 59. Cost-effectiveness of ursodiol: the creature from the black box.
    Diehl AK
    J Gen Intern Med; 1990; 5(4):374-5. PubMed ID: 2115578
    [No Abstract]   [Full Text] [Related]  

  • 60. [Study on the ursodeoxycholate treatment of gallstones with special reference to course of disappearance and recurrence].
    Shibaya H; Okamura H; Kokubu S; Toyama K; Kiyohashi A; Okabe H
    Nihon Shokakibyo Gakkai Zasshi; 1982 Jul; 79(7):1443-5. PubMed ID: 7143774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.